The 2 groups had similar mean ages, serum CEA levels, distributions of primary and metastatic tumor locations, frequencies of comorbid medical conditions, numbers of liver metastases, largest size of hepatic metastases, and frequencies of receiving targeted therapy. The gene discussed is CEACAM5; the disease is metastatic neoplasm.